What is Benign Prostatic Hyperplasia (BPH)?

Benign prostatic hyperplasia (BPH) is one of the most common urological conditions among men, with the incidence increasing with age. Approximately 70% of men between the ages of 60 and 69 are affected, with the prevalence rising to 80% over the age of 70.

Therapeutic Options

Our team is experienced in minimally invasive treatments tailored to prostate size, patient age, and ejaculation preservation techniques.

Rezum

The treatment is performed under local anesthesia. Through a small tube inserted into the urethra, steam is injected inside the prostate to reduce prostate tissue and the size of the gland.

HOLEP Laser

Holmium laser enucleation of the prostate (HoLEP) is an advanced surgical technique for the treatment of benign prostatic hyperplasia, recognized and recommended by major urologic guidelines. It represents an effective alternative to endoscopic treatment. It also allows treatment of bulky prostates, which in the past would have required open surgery.

THULEP Laser

Thulium Laser Enucleation of the Prostate (ThuLEP) is a minimally invasive technique for prostate resection that replicates the results of open surgery while minimizing bleeding and allowing patient discharge within 1-2 days.

Robotic-assisted prostate adenomectomy (RARP)

Robotic-assisted prostatectomy (RARP) involves removal of the prostate and seminal vesicles, followed by anastomosis between the bladder neck and the urethral stump, thus restoring continuity of the urinary tract interrupted by the removal of the gland. At the end of the procedure, a bladder catheter is inserted. In some cases, removal of loco-regional lymph nodes may also be indicated.

Urology and Andrology Services at UPMC Salvator Mundi International Hospital

We offer comprehensive urology and andrology services for prevention, diagnosis and treatment of diseases of the genito-urinary system.